Search
for

    Glossary Adrenal-Dependent Hyperadrenocorticism

    condition where adrenal tumors cause excessive cortisol production

    Adrenal-Dependent Hyperadrenocorticism (ADH), also known as adrenal-dependent Cushing's syndrome, is a condition where the adrenal glands produce excessive amounts of cortisol due to a tumor in one or both adrenal glands. This overproduction of cortisol can lead to symptoms such as weight gain, thinning skin, hair loss, and high blood pressure.

    Related Terms

    Research 10 of 1000+

    1. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane American journal of veterinary research · 2002 · 116 citations
    2. Pituitary-dependent hyperadrenocorticism in a cat Journal of the American Veterinary Medical Association · 1986 · 29 citations
    3. Pituitary Dependent Hyperadrenocorticism in a Golden Lion Tamarin (Leontopithecus rosalia) International Journal of Zoology and Animal Biology · 2020 · 1 citations
    4. Clinical and Imagistic Aspects in Dog’s Hyperadrenocorticism Determined by Pituitary and Adrenal Nodules with Secretory Function Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca Veterinary Medicine · 2015
    5. Pituitary-dependent hyperadrenocorticism in a terrier dog: A case report Journal of Coastal Life Medicine · 2016
    6. Trilostane treatment of a dog with functional adrenocortical neoplasia 2003 · 40 citations
    7. Prevalence of Systemic Hypertension and Control of Systolic Blood Pressure in a Cohort of 14 Dogs with Adrenal-Dependent Hypercortisolism during the First Year of Trilostane Treatment or after Adrenalectomy Animals · 2024
    8. Hyperadrenocorticism in Ferrets 2013 · 6 citations
    9. Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment Journal of feline medicine and surgery open reports · 2021 · 2 citations
    10. Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®) BMC veterinary research · 2021 · 2 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →